A project identifying potential risk factors leading to diabetic ketoacidosis in patients with type 1 diabetes treated with an insulin pump
Chantelle M Caines, Abigail Shaw, ANDREW M. SOLOMON
Abstract
Open-access reader
Chantelle M Caines, Abigail Shaw, ANDREW M. SOLOMON
Abstract
Open-access reader
Diabetic ketoacidosis (DKA) is a life threatening condition in people with type 1 diabetes (T1D).[1][1] With 10–30% of people in developed countries on insulin pump therapy for managing T1D, DKA in such patients can result in fatal or near-fatal consequences.[2][2]–[4][3] Despite its severity,
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Diabetic ketoacidosis (DKA) is a life threatening condition in people with type 1 diabetes (T1D).[1][1] With 10–30% of people in developed countries on insulin pump therapy for managing T1D, DKA in such patients can result in fatal or near-fatal consequences.[2][2]–[4][3] Despite its severity,
Key concepts: Diabetic ketoacidosis, Medicine, Type 1 diabetes, Insulin pump, Diabetes mellitus, Insulin, Ketoacidosis, Intensive care medicine